Skip to main content

Peer Review reports

From: Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions

Original Submission
1 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Jan 2022 Reviewed Reviewer Report - Jianwei Xuan
10 Jan 2022 Reviewed Reviewer Report - Andreas Kuznik
13 Jan 2022 Reviewed Reviewer Report
25 Jan 2022 Author responded Author comments - Tara Klemencic Kozul
Resubmission - Version 3
25 Jan 2022 Submitted Manuscript version 3
11 Feb 2022 Author responded Author comments - Tara Klemencic Kozul
Resubmission - Version 4
11 Feb 2022 Submitted Manuscript version 4
25 Feb 2022 Author responded Author comments - Tara Klemencic Kozul
Resubmission - Version 5
25 Feb 2022 Submitted Manuscript version 5
4 Mar 2022 Reviewed Reviewer Report - Andreas Kuznik
7 Mar 2022 Reviewed Reviewer Report - Jianwei Xuan
29 Mar 2022 Reviewed Reviewer Report
13 Apr 2022 Author responded Author comments - Tara Klemencic Kozul
Resubmission - Version 6
13 Apr 2022 Submitted Manuscript version 6
20 Apr 2022 Author responded Author comments - Tara Klemencic Kozul
Resubmission - Version 7
20 Apr 2022 Submitted Manuscript version 7
7 Jun 2022 Reviewed Reviewer Report - Jianwei Xuan
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
7 Jun 2022 Editorially accepted
12 Jul 2022 Article published 10.1186/s12913-022-08210-z

You can find further information about peer review here.

Back to article page